Organization
Aerie Pharmaceuticals
11 clinical trials
Clinical trial
A Phase 1/2 Two-Stage Dose Escalation and Randomized Parallel-Group Study to Evaluate the Safety, Preliminary Treatment Effects, and Durability of AR-14034 Sustained Release Implant Compared to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment in Participants With Neovascular Age-Related Macular DegenerationStatus: Recruiting, Estimated PCD: 2027-02-01
Clinical trial
A Multicenter, Open-Label Rocklatan® (Netarsudil/Latanoprost Ophthalmic Solution) 0.02%/0.005% Evaluation of IOP Lowering Efficacy and Safety as Replacement of Current Medical Therapy Regimen for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular HypertensionStatus: Completed, Estimated PCD: 2023-03-22
Clinical trial
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 MonthsStatus: Completed, Estimated PCD: 2013-04-01
Clinical trial
First-in-Human Study of the Safety of AR-13503 Sustained Release Intravitreal Implant in Subjects With Neovascular Age-Related Macular Degeneration (nAMD) and Subjects With Diabetic Macular Edema (DME)Status: Completed, Estimated PCD: 2022-05-12
Clinical trial
A Phase 3 Study Evaluating the Safety and Efficacy of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dry Eye Disease (COMET-3)Status: Completed, Estimated PCD: 2023-10-17
Clinical trial
A Phase 3 Study Evaluating the Safety and Efficacy of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dry Eye Disease (COMET-2)Status: Completed, Estimated PCD: 2023-07-21
Clinical trial
An Open-label Study Assessing the Ocular and Systemic Safety and Systemic Absorption of AR-13324 Ophthalmic Solution, 0.02% in Healthy VolunteersStatus: Completed, Estimated PCD: 2013-11-01
Clinical trial
A Single-masked, Randomized, Multi-center, Parallel-group, 4-week Study Evaluating the Efficacy and Safety of Once Daily Netarsudil Ophthalmic Solution 0.02% Compared to Twice Daily Ripasudil Hydrochloride Hydrate Ophthalmic Solution 0.4% in Japanese Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)Status: Completed, Estimated PCD: 2021-07-09
Clinical trial
A Randomized, Open-Label, Parallel-Group Study to Evaluate the Safety and Efficacy of Two Dosing Regimens of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal DystrophyStatus: Completed, Estimated PCD: 2021-08-11
Clinical trial
A Long-Term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dry Eye Disease (COMET-4)Status: Completed, Estimated PCD: 2024-02-28
Clinical trial
A Phase 3 Study Evaluating the Safety and Efficacy of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dry Eye Disease (COMET-3)Status: Completed, Estimated PCD: 2023-10-17